China Cancer Drugs ne India mein machaya Bawaal! Western Pharma ki prices hui collapse, Indians ko mila sasta ilaaj!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
China Cancer Drugs ne India mein machaya Bawaal! Western Pharma ki prices hui collapse, Indians ko mila sasta ilaaj!
Overview

Bhaiyo, India mein cancer ke ilaaj ka kharcha ab seedha aadha ho jayega! Kiske wajah se? China se aa rahi hai ekdum sasti immunotherapy, jo local companies ne launch ki hai. Western drugs jahan **₹1-2 Lakh** per vial maangte hain, wahi ye naye drugs **₹50,000** per session mein mil rahe hain. Isse na sirf zyada patients ko ilaaj milega, balki bade pharma companies ki bhi neend ud gayi hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Dekho yaar, situation kya hai. Western immunotherapies, jaise Keytruda, ek vial ke ₹1-2 Lakh tak padti hain. Opdivo bhi ₹50,000 se ₹100,000 tak aata hai. Saalon ka ilaaj karte karte ₹10 Lakh se bhi upar ka kharcha ho jata hai, tab bhi 34% se lekar 84% patients ko takleef hoti hai. Lekin ab jo Chinese drugs aa rahe hain, woh ₹50,000 per session mein mil rahe hain. Matlab saal ka kharcha pakad lo ₹3.5-4.5 Lakh ke aas paas, jo kafi kam hai.

Is saste daam ka fayda uthane ke liye, India ki badi pharma companies ne China se deals pakki kar li hain. Jaise Intas Pharmaceuticals ne Shanghai Henlius Biotech se serplulizumab launch kiya hai lung cancer ke liye. Glenmark Pharmaceuticals ne Beigene se tesilizumab aur Jiangsu Hengrui se trastuzumab rezetecan, plus Jiangsu Hansoh se aumolertinib li hai. Aur Dr. Reddy's Laboratories ne Shanghai Junshi Biosciences ke saath milkar toripalimab laya hai. Ye sab partnerships bahut important hain taaki sabko sasta aur accha ilaaj mil sake.

Abhi log soch rahe honge ki China ke drugs quality mein kaise hain? Toh doctors ka kehna hai ki ye drugs bhi standard clinical trials se guzre hain aur unki response rate, progression-free survival aur overall survival, Western drugs jitni hi acchi hai. Matlab quality mein koi compromise nahi hai. Ye collaborations badhte hi ja rahe hain, aur experts ka anuman hai ki aane wale 10 saalon mein Asian drugs, cancer se lekar diabetes aur weight loss tak, America aur Europe ke products ko replace kar denge.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.